Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results.
21 auth. R. Motzer, A. Ravaud, J. Patard, H. Pandha, D. George, Anup Patel, Yen‐Hwa Chang, B. Escudier, F. Donskov, A. Magheli, ... G. Cartenì, B. Laguerre, P. Tomczak, J. Breza, P. Gerletti, M. Lechuga, Xun Lin, M. Casey, L. Serfass, A. Pantuck, M. Staehler